{"id":"W2089311432","doi":"10.1182/blood-2012-05-425934","title":"A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":655,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Calgary; University of Toronto","funders":"National Cancer Institute; Jewish General Hospital; Onyx Pharmaceuticals; University of Alberta; Wake Forest University","keywords":"Carfilzomib; Multiple myeloma; Refractory (planetary science); Medicine; Pomalidomide; Lenalidomide; Oncology; Internal medicine; Materials science","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001587977,0.0001954697,0.0003881119,0.0001921879,0.00004892073,0.0000089095,0.0000609156,0.00006577609,0.00003341689],"category_scores_gemma":[0.0001863781,0.0001403719,0.00003349422,0.0002080009,0.00006127597,0.0001392189,0.0000633877,0.0001666606,0.000008485644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006708079,"about_ca_system_score_gemma":0.00004389559,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002396821,"about_ca_topic_score_gemma":0.0001252141,"domain_scores_codex":[0.9983955,0.0001061178,0.0003014719,0.0002702362,0.0004918594,0.0004348309],"domain_scores_gemma":[0.9990034,0.00009617886,0.0001057243,0.0003639076,0.00009086614,0.0003399347],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00258495,0.07736052,0.9093176,0.00006401713,0.0003063054,0.00008857243,0.002005789,1.901216e-7,0.002965293,6.982081e-7,0.00002056366,0.005285488],"study_design_scores_gemma":[0.1235969,0.01122738,0.8600217,0.00008932954,0.0002014748,0.000007356677,0.0005779993,0.000009177719,0.004022155,6.271312e-7,0.0001266684,0.0001193011],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977832,0.0003295664,0.000001629311,0.00001385685,0.00003781768,0.001508681,0.00002789575,0.00002418741,0.0002731002],"genre_scores_gemma":[0.9993278,0.00001055082,0.0003571771,0.00001658495,0.00004260646,0.00007181714,0.00005913069,0.00003121631,0.00008311165],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1210119,"threshold_uncertainty_score":0.5724199,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02848352810245834,"score_gpt":0.2876643652637208,"score_spread":0.2591808371612624,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}